Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q4 2023 Earnings

27MarConfirmed

Q4 2022

Q2 2023

Q3 2023

Q4 2023

-1.19

-0.79

-0.4

0

Details

Expected EPS

-0.85

Actual EPS

-0.64

Surprise EPS

0.21

Surprise Percent

+24.71%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.64 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.